Tag: tsx:blu
November 14, 2019
BELLUS Health Reports Q3 Financial Results
The company also noted that the first patient was enrolled in its Phase 2 RELIEF Trial of BLU-5937 for chronic... September 3, 2019
Bellus Health Launches US$60 Million Public Offering and Files to List Shares on NASDAQ
BELLUS Health (TSX:BLU) has announced it has filed a prospectus supplement to its short form base shelf prospectus together with...
July 9, 2019
3 Top Pharma Stocks on the TSX Year-to-Date
At the halfway mark of the year, it's time to look back on the top performing pharma stocks on the...
May 1, 2019
BBHIC 2019, Day 2: Notes From the Floor
The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
April 10, 2019
5 Top Pharma Stocks on the TSX Year-to-Date
With the first quarter of 2019 over, it's time to look back on the top performing pharma stocks on the... April 3, 2019
BELLUS Health Receives Clearance of U.S. IND for BLU-5937 Phase 2 Study in Chronic Cough Patients
BELLUS Health ((TSX:BLU) has announced that the US Food and Drug Administration (FDA) has accepted Bellus’ investigational new drug (IND)...
December 20, 2018